Globus Medical (GMED) Tops Q2 EPS by 4c, beats revenue

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $291.62 million versus the consensus estimate of $279.53 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• RH (RH) Tops Q1 EPS by 12c